272 results Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b Stibbe advises EFG Hermes Stibbe advises EFG Hermes Private Equity on the acquisition by Vortex, its renewable energy platform, of a 365 MW solar energy portfolio in the UK from TerraForm Power with an enterprise value of approximately GBP 470 million. Stibbe advises The Blackstone Group Stibbe advises The Blackstone Group. Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises Vestar Capital Partners Advising on the sale of one of the world's largest manufacturers of wheelchairs, Sunrise Medical, to Equistone Partners Europe. Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital. Stibbe advises Silver Lake Advising private equity investor Silver Lake on the EUR 1 billion acquisition of Global Blue. Stibbe advises UCC Holdings Co Advising the Japanese coffee company UCC Holdings Co. on the acquisition of United Coffee (formerly the Dutch "Three Moles") from CapVest Equity Partners. Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Stibbe advises Unitas Capital Advising private equity firm Unitas Capital on the EUR 525 million acquisition of Hyva Holding from 3i Group. Stibbe advises Gamma Holding Advising Gamma Holding (the world wide producer of high-quality textile fabrics) on the public offer by private equity investors Gilde Buy Out Partners and Parcom Capital Management. Pagination Previous page Page 13 Current page 14 Page 15 Page 16 Next page
Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b
Stibbe advises EFG Hermes Stibbe advises EFG Hermes Private Equity on the acquisition by Vortex, its renewable energy platform, of a 365 MW solar energy portfolio in the UK from TerraForm Power with an enterprise value of approximately GBP 470 million.
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises Vestar Capital Partners Advising on the sale of one of the world's largest manufacturers of wheelchairs, Sunrise Medical, to Equistone Partners Europe.
Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital.
Stibbe advises Silver Lake Advising private equity investor Silver Lake on the EUR 1 billion acquisition of Global Blue.
Stibbe advises UCC Holdings Co Advising the Japanese coffee company UCC Holdings Co. on the acquisition of United Coffee (formerly the Dutch "Three Moles") from CapVest Equity Partners.
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Stibbe advises Unitas Capital Advising private equity firm Unitas Capital on the EUR 525 million acquisition of Hyva Holding from 3i Group.
Stibbe advises Gamma Holding Advising Gamma Holding (the world wide producer of high-quality textile fabrics) on the public offer by private equity investors Gilde Buy Out Partners and Parcom Capital Management.